Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 753.97 Million CNY | 31.07% |
| 2022 | 575.25 Million CNY | 20.02% |
| 2021 | 479.31 Million CNY | 42.18% |
| 2020 | 337.12 Million CNY | 31.83% |
| 2019 | 255.72 Million CNY | 32.73% |
| 2018 | 192.67 Million CNY | 25.97% |
| 2017 | 152.95 Million CNY | 45.22% |
| 2016 | 105.32 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 190.37 Million CNY | -9.2% |
| 2024 Q3 | 184.66 Million CNY | -3.0% |
| 2024 Q1 | 209.65 Million CNY | -3.2% |
| 2023 Q3 | 173.19 Million CNY | -4.24% |
| 2023 Q1 | 183.32 Million CNY | 5.05% |
| 2023 FY | 753.97 Million CNY | 31.07% |
| 2023 Q4 | 216.59 Million CNY | 25.06% |
| 2023 Q2 | 180.85 Million CNY | -1.35% |
| 2022 Q3 | 130.38 Million CNY | -4.59% |
| 2022 Q2 | 136.66 Million CNY | 2.23% |
| 2022 Q1 | 133.68 Million CNY | -5.78% |
| 2022 FY | 575.25 Million CNY | 20.02% |
| 2022 Q4 | 174.51 Million CNY | 33.85% |
| 2021 Q3 | 116.97 Million CNY | 1.69% |
| 2021 FY | 479.31 Million CNY | 42.18% |
| 2021 Q4 | 141.87 Million CNY | 21.29% |
| 2021 Q2 | 115.03 Million CNY | 9.11% |
| 2021 Q1 | 105.43 Million CNY | 16.33% |
| 2020 Q4 | 90.63 Million CNY | 2.14% |
| 2020 Q3 | 88.73 Million CNY | 4.64% |
| 2020 Q1 | 72.95 Million CNY | -0.46% |
| 2020 FY | 337.12 Million CNY | 31.83% |
| 2020 Q2 | 84.8 Million CNY | 16.24% |
| 2019 Q2 | 66.65 Million CNY | 18.92% |
| 2019 FY | 255.72 Million CNY | 32.73% |
| 2019 Q4 | 73.29 Million CNY | 22.7% |
| 2019 Q3 | 59.73 Million CNY | -10.38% |
| 2019 Q1 | 56.04 Million CNY | -9.73% |
| 2018 Q4 | 62.09 Million CNY | 0.0% |
| 2018 FY | 192.67 Million CNY | 25.97% |
| 2017 FY | 152.95 Million CNY | 45.22% |
| 2016 FY | 105.32 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 275.49 Million CNY | -173.676% |